Status:
UNKNOWN
Drug-drug Interaction Between Simvastatin and SHR3824
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Conditions:
Type 2 Diabetes
Eligibility:
MALE
18-45 years
Phase:
PHASE1
Brief Summary
the purpose of thr study is to investigate the potential interation between multiple oral doses of SHR3824 and single oral dose of Simvastatin in healthy adult volunteers.
Eligibility Criteria
Inclusion
- Healthy male volunteers with a body mass index (BMI, a measure of a person's weight in relation to height) between 19 and 26 kg/m2
Exclusion
- History of hypoglycemia
- History of urinary tract infections,or genital infections
- History of current clinically significant medical illness as determined by the Investigator
- Known allergy to SHR3824 or Simvastatin or any of the excipients of the formulation of SHR3824 or Simvastatin
Key Trial Info
Start Date :
November 24 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 8 2017
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03329118
Start Date
November 24 2017
End Date
December 8 2017
Last Update
November 9 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.